Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$314,550
+$42,688 QoQ
Shares Held
1,250
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#3,588
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPH & CO holds $2,307,781 across 8 Drug Manufacturers - General names. ABBV ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,734 | $948,323 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,799 | $479,965 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,045 | $463,552 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,250 | $314,550 | |
| 5 | PFE |
Pfizer Inc
|
1,695 | $40,815 | |
| 6 | GSK |
GSK plc
|
527 | $27,625 | |
| 7 | BIIB |
Biogen Inc.
|
97 | $20,957 | |
| 8 | LLY |
ELI LILLY & Co
|
10 | $11,994 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $314,550 | 1,250 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $271,862 | 1,250 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $308,461 | 1,350 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $312,579 | 1,350 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $250,587 | 1,350 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $282,852 | 1,350 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $239,895 | 1,350 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $266,598 | 1,350 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $248,704 | 1,450 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $488,938 | 2,685 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $416,094 | 2,685 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $417,964 | 2,804 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $375,223 | 2,785 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $443,845 | 2,785 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $450,083 | 2,785 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $373,774 | 2,785 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $426,550 | 2,785 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $451,476 | 2,785 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $377,089 | 2,785 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $300,417 | 2,785 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $313,702 | 2,785 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $301,392 | 2,785 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $298,412 | 2,785 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $243,938 | 2,785 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $321,244 | 3,272 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $759,766 | 9,972 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||